These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 20861609)

  • 1. Management of polycystic ovary syndrome in childhood and adolescence.
    Ojaniemi M; Tapanainen P; Morin-Papunen L
    Horm Res Paediatr; 2010; 74(5):372-5. PubMed ID: 20861609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
    Spritzer PM; Motta AB
    Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.
    Harwood K; Vuguin P; DiMartino-Nardi J
    Horm Res; 2007; 68(5):209-17. PubMed ID: 17426408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-lowering agents in the management of polycystic ovary syndrome.
    De Leo V; la Marca A; Petraglia F
    Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCOS in adolescence and type 2 diabetes.
    Carreau AM; Baillargeon JP
    Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of polycystic ovarian syndrome in adolescents.
    Brewer M; Pawelczak M; Kessler M; Shah B
    Minerva Pediatr; 2010 Oct; 62(5):459-73. PubMed ID: 20940680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovarian syndrome.
    Madnani N; Khan K; Chauhan P; Parmar G
    Indian J Dermatol Venereol Leprol; 2013; 79(3):310-21. PubMed ID: 23619436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome.
    Kahn JA; Gordon CM
    Adolesc Med; 1999 Jun; 10(2):321-36. PubMed ID: 10370713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A; Szabó I
    Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.